Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics.

@article{Sapan2007AntibodyT,
  title={Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics.},
  author={Christine V Sapan and Howard M. Reisner and Roger L. Lundblad},
  journal={Vox sanguinis},
  year={2007},
  volume={92 3},
  pages={197-205}
}
BACKGROUND AND OBJECTIVES Intravenous immunoglobulin (IVIG) is used for an increasingly diverse number of therapeutic applications as an immunomodulation drug. Although it has demonstrated therapeutic effectiveness, the mechanism of action of IVIG in these disorders is poorly understood; this lack of understanding complicates rational clinical application and reimbursement for 'off-label' use. MATERIALS AND METHODS Selected literature on the clinical use of IVIG as an immunomodulation drug is… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…